Precision Optics (POCI) Competitors $4.23 -0.01 (-0.24%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$4.24 +0.00 (+0.12%) As of 10/14/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock POCI vs. INO, HYPR, PDEX, APYX, OBIO, NSPR, FONR, NTRB, ZJYL, and PSTVShould you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Pro-Dex (PDEX), Apyx Medical (APYX), Orchestra BioMed (OBIO), InspireMD (NSPR), Fonar (FONR), Nutriband (NTRB), Jin Medical International (ZJYL), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Precision Optics vs. Its Competitors Inovio Pharmaceuticals Hyperfine Pro-Dex Apyx Medical Orchestra BioMed InspireMD Fonar Nutriband Jin Medical International Plus Therapeutics Precision Optics (NASDAQ:POCI) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment. Do insiders and institutionals believe in POCI or INO? 13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by insiders. Comparatively, 2.3% of Inovio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, POCI or INO? Precision Optics has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Which has stronger valuation & earnings, POCI or INO? Precision Optics has higher revenue and earnings than Inovio Pharmaceuticals. Precision Optics is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecision Optics$19.09M1.71-$5.78M-$0.84-5.04Inovio Pharmaceuticals$182.34K711.15-$107.25M-$2.61-0.93 Does the media favor POCI or INO? In the previous week, Inovio Pharmaceuticals had 1 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Inovio Pharmaceuticals and 2 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.95 beat Inovio Pharmaceuticals' score of 0.91 indicating that Precision Optics is being referred to more favorably in the media. Company Overall Sentiment Precision Optics Positive Inovio Pharmaceuticals Positive Is POCI or INO more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Precision Optics' net margin of -30.28%. Precision Optics' return on equity of -51.33% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Precision Optics-30.28% -51.33% -31.18% Inovio Pharmaceuticals N/A -163.32%-96.41% Do analysts prefer POCI or INO? Inovio Pharmaceuticals has a consensus price target of $8.80, indicating a potential upside of 260.66%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Inovio Pharmaceuticals 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29 SummaryInovio Pharmaceuticals beats Precision Optics on 9 of the 16 factors compared between the two stocks. Get Precision Optics News Delivered to You Automatically Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POCI vs. The Competition Export to ExcelMetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.71M$7.00B$6.04B$10.50BDividend YieldN/A1.18%5.73%4.80%P/E Ratio-5.0426.7984.6427.24Price / Sales1.7127.55508.12197.88Price / CashN/A21.5837.5761.53Price / Book2.645.1812.256.74Net Income-$5.78M$178.09M$3.32B$276.59M7 Day Performance-2.76%-2.86%-1.34%-0.47%1 Month Performance-3.64%5.12%8.14%7.47%1 Year Performance1.20%5.21%72.27%34.58% Precision Optics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POCIPrecision Optics0.9153 of 5 stars$4.23-0.2%N/A-0.5%$32.71M$19.09M-5.0480INOInovio Pharmaceuticals3.8076 of 5 stars$2.39-0.8%$8.80+268.2%-57.2%$128.07M$220K-0.92320Gap DownHYPRHyperfine1.078 of 5 stars$1.72+13.2%$1.28-25.4%+106.2%$119.44M$12.89M-3.31190High Trading VolumePDEXPro-Dex3.0554 of 5 stars$32.82-3.0%$56.00+70.6%-9.4%$110.39M$66.59M12.16140News CoverageAPYXApyx Medical1.6788 of 5 stars$2.84-1.7%N/A+193.1%$109.30M$48.10M-6.31270Gap DownHigh Trading VolumeOBIOOrchestra BioMed3.1795 of 5 stars$2.73-1.4%$13.50+394.5%-31.1%$107.04M$2.64M-1.494NSPRInspireMD2.9072 of 5 stars$2.42-3.2%$4.50+86.0%-10.2%$100.97M$7.07M-3.2350FONRFonar1.5698 of 5 stars$15.89-0.7%N/A+3.1%$99.25M$104.35M12.92480News CoverageAnalyst ForecastNTRBNutriband2.2358 of 5 stars$7.84flat$13.00+65.8%-5.7%$94.35M$2.14M-2.7310Gap DownZJYLJin Medical InternationalN/A$0.50-11.9%N/A-85.0%$88.87M$23.50M0.00245High Trading VolumePSTVPlus Therapeutics3.768 of 5 stars$0.82-7.7%$8.00+874.3%-46.7%$88.30M$5.82M-0.3720Gap Down Related Companies and Tools Related Companies INO Alternatives HYPR Alternatives PDEX Alternatives APYX Alternatives OBIO Alternatives NSPR Alternatives FONR Alternatives NTRB Alternatives ZJYL Alternatives PSTV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POCI) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision Optics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision Optics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
